The kynurenine pathway of tryptophan degradation as a drug target

Current Opinion in Pharmacology

Volumn 4, Issue 1, 2004, Pages 12-17

  Schwarcz, Robert ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 CHLORO 3 HYDROXYANTHRANILIC ACID; GAMMA INTERFERON; GLUTAMATE RECEPTOR; GLYCINE RECEPTOR; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINASE; KYNURENINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; N METHYLTRYPTOPHAN; QUINOLINIC ACID; TACROLIMUS; TRYPTOPHAN;

ARTICLE; DEGRADATION; DRUG DESIGN; DRUG EFFICACY; DRUG METABOLISM; DRUG SCREENING; DRUG TARGETING; ENZYMATIC DEGRADATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; MAMMAL CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; TRYPTOPHAN METABOLISM;

EID: 0742323784     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2003.10.006     Document Type: Review

References (59)

1. Schwarcz R, Young SN, Brown RR: Kynurenine and Serotonin Pathways: Progress in Tryptophan Research. New York: Plenum; 1991.
2. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids Pharmacol. Rev. 45 1993 309-379
3. Moroni F. Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites Eur. J. Pharmacol. 375 1999 87-100
4. Stone T.W. Darlington L.G. Endogenous kynurenines as targets for drug discovery and development Nat. Rev. Drug. Discov. 1 2002 609-620
5. Schwarcz R. Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities J. Pharmacol. Exp. Ther. 303 2002 1-10
6. Frumento G. Rotondo R. Tonetti M. Damonte G. Benatti U. Ferrara G.B. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase J. Exp. Med. 196 2002 459-468
7. Fallarino F. Grohmann U. Vacca C. Bianchi R. Orabona C. Spreca A. Fioretti M.C. Puccetti P. T cell apoptosis by tryptophan catabolism Cell Death Differ 9 2002 1069-1077
8. Terness P. Bauer T.M. Rose L. Dufter C. Watzlik A. Simon H. Opelz G. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites J. Exp. Med. 196 2002 447-457
9. Guillemin G.J. Kerr S.J. Pemberton L.A. Smith D.G. Smythe G.A. Armati P.J. Brew B.J. IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment J. Interferon. Cytokine Res. 21 2001 1097-1101
10. Chiarugi A. Calvani M. Meli E. Traggiai E. Moroni F. Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages J. Neuroimmunol. 120 2001 190-198
11. Guillemin G.J. Kerr S.J. Pemberton L.A. Smith D.G. Smythe G.A. Armati P.J. Brew B.J. IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment J. Interferon Cytokine. Res. 21 2001 1097-1101
12. Mahnke K. Schmitt E. Bonifaz L. Enk A.H. Jonuleit H. Immature, but not inactive: the tolerogenic function of immature dendritic cells Immunol. Cell Biol. 80 2002 477 483
13. Mellor A.L. Baban B. Chandler P. Marshall B. Jhaver K. Hansen A. Koni P.A. Iwashima M. Munn D.H. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion J. Immunol. 171 2003 1652-1655
14. Lee G.K. Park H.J. Macleod M. Chandler P. Munn D.H. Mellor A.L. Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division Immunology 107 2002 452-460
15. Moffett J.R. Namboodiri M.A. Tryptophan and the immune response Immunol. Cell. Biol. 81 2003 247-265
16. Grohmann U. Fallarino F. Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO Trends Immunol. 24 2003 242-248
17. Grant R.S. Passey R. Matanovic G. Smythe G. Kapoor V. Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism? Arch. Biochem. Biophys. 372 1999 1-7
18. Naritsin D.B. Saito K. Markey S.P. Chen C.Y. Heyes M.P. Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate J. Neurochem. 65 1995 2217-2226
19. Guillemin G.J. Kerr S.J. Smythe G.A. Smith D.G. Kapoor V. Armati P.J. Croitoru J. Brew B.J. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection J. Neurochem. 78 2001 842-853
20. Kiss C. Ceresoli-Borroni G. Guidetti P. Zielke C.L. Zielke H.R. Schwarcz R. Kynurenate production by cultured human astrocytes J. Neural. Transm. 110 2003 1-14
21. Kita T. Morrison P.F. Heyes M.P. Markey S.P. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain J. Neurochem. 82 2002 258-268
22. Lehrmann E. Molinari A. Speciale C. Schwarcz R. Immunohistochemical visualization of newly formed quinolinate in the normal and excitotoxically lesioned rat striatum Exp. Brain Res. 141 2001 389-397
23. Hilmas C. Pereira E.F. Alkondon M. Rassoulpour A. Schwarcz R. Albuquerque E.X. The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications J. Neurosci. 21 2001 7463-7473
24. Shepard P.D. Joy B. Clerkin L. Schwarcz R. Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat Neuropsychopharmacology 28 2003 1454 1462
25. Santamaria A. Flores-Escartin A. Martinez J.C. Osorio L. Galvan-Arzate S. Chaverri J.P. Maldonado P.D. Medina-Campos O.N. Jimenez-Capdeville M.E. Manjarrez J. Rios C. Copper blocks quinolinic acid neurotoxicity in rats: contribution of antioxidant systems Free Radic. Biol. Med. 35 2003 418-427
26. Santamaria A. Salvatierra-Sanchez R. Vazquez-Roman B. Santiago-Lopez D. Villeda-Hernandez J. Galvan-Arzate S. Jimenez-Capdeville M.E. Ali S.F. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies J. Neurochem. 86 2003 479-488
27. Guillemin G.J. Croitoru-Lamoury J. Dormont D. Armati P.J. Brew B.J. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes Glia 41 2003 371 381
28. Baran H. Staniek K. Kepplinger B. Stur J. Draxler M. Nohl H. Kynurenines and the respiratory parameters on rat heart mitochondria Life Sci. 72 2003 1103-1115
29. Vazquez S. Aquilina J.A. Jamie J.F. Sheil M.M. Truscott R.J. Novel protein modification by kynurenine in human lenses J. Biol. Chem. 277 2002 4867-4873
30. Carpenedo R. Pittaluga A. Cozzi A. Attucci S. Galli A. Raiteri M. Moroni F. Presynaptic kynurenate-sensitive receptors inhibit glutamate release Eur. J. Neurosci. 13 2001 2141-2147
31. Schwieler L. Erhardt S. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid Neuropsychopharmacology 28 2003 1770-1777
32. Erhardt S. Schwieler L. Engberg G. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine Synapse 43 2002 227-237
33. Sas K. Csete K. Vecsei L. Papp J.G. Effect of systemic administration of L-kynurenine on corticocerebral blood flow under normal and ischemic conditions of the brain in conscious rabbits J. Cardiovasc. Pharmacol. 42 2003 403-409
34. Stazka J. Luchowski P. Wielosz M. Kleinrok Z. Urbanska E.M. Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine Eur. J. Pharmacol. 448 2002 133-137
35. Nicholls T. Nitsos I. Smythe G. Walker D.W. Kynurenine production and catabolism in fetal sheep with embolized or nonembolized placentas Am. J. Obstet. Gynecol. 185 2001 988-995
36. Topczewska-Bruns J. Pawlak D. Chabielska E. Tankiewicz A. Buczko W. Increased levels of 3-hydroxykynurenine in different brain regions of rats with chronic renal insufficiency Brain Res. Bull. 58 2002 423-428
37. Holt D.E. Washabau R.J. Djali S. Dayrell-Hart B. Drobatz K.J. Heyes M.P. Robinson M.B. Cerebrospinal fluid glutamine, tryptophan, and tryptophan metabolite concentrations in dogs with portosystemic shunts Am. J. Vet. Res. 63 2002 1167-1171
38. Medana I.M. Day N.P. Salahifar-Sabet H. Stocker R. Smythe G. Bwanaisa L. Njobvu A. Kayira K. Turner G.D. Taylor T.E. Hunt N.H. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria J. Infect. Dis. 188 2003 844-849
39. Ilzecka J. Kocki T. Stelmasiak Z. Turski W.A. Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis Acta Neurol. Scand. 107 2003 412-418
40. Rejdak K. Bartosik-Psujek H. Dobosz B. Kocki T. Grieb P. Giovannoni G. Turski W.A. Stelmasiak Z. Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients Neurosci. Lett. 331 2002 63-65
41. Ceresoli-Borroni G. Schwarcz R. Neonatal asphyxia in rats: acute effects on cerebral kynurenine metabolism Pediatr. Res. 50 2001 231-235
42. Forrest C.M. Youd P. Kennedy A. Gould S.R. Darlington L.G. Stone T.W. Purine, kynurenine, neopterin and lipid peroxidation levels in inflammatory bowel disease J. Biomed. Sci. 9 2002 436-442
43. Guidetti P, Schwarcz R: 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's Disease? In Progress in Tryptophan Research. Edited by Allegri Filippini G, Costa CVL. Hingham, MA: Kluwer; in press.
44. Schwarcz R. Rassoulpour A. Wu H.-Q. Medoff D. Tamminga C.A. Roberts R.C. Increased cortical kynurenate content in schizophrenia Biol. Psychiatry 50 2001 521-530
45. Mosca M. Croci C. Mostardini M. Breton J. Malyszko J. Avanzi N. Toma S. Benatti L. Gatti S. Tissue expression and translational control of rat kynurenine aminotransferase/glutamine transaminase K mRNAs Biochim. Biophys. Acta 1628 2003 1-10
46. Csillik A.E. Okuno E. Csillik B. Knyihar E. Vecsei L. Expression of kynurenine aminotransferase in the subplate of the rat and its possible role in the regulation of programmed cell death Cereb. Cortex 12 2002 1193-1201
47. Kwok J.B. Kapoor R. Gotoda T. Iwamoto Y. Iizuka Y. Yamada N. Isaacs K.E. Kushwaha V.V. Church W.B. Schofield P.R. Kapoor V. A missense mutation in kynurenine aminotransferase-1 in spontaneously hypertensive rats J. Biol. Chem. 277 2002 35779-35782
48. Yu P, Di Prospero NA, Sapko MT, Cai T, Chen A, Melendez-Ferro M, Du F, Whetsell WO Jr, Guidetti P, Schwarcz R, Tagle DA: Biochemical and phenotypic abnormalities in kynurenine aminotransferase II-deficient mice. Submitted for publication.
49. Rejdak R. Zarnowski T. Turski W.A. Okuno E. Kocki T. Zagorski Z. Kohler K. Guenther E. Zrenner E. Presence of kynurenic acid and kynurenine aminotransferases in the inner retina Neuroreport 12 2001 3675-3678
50. Mizutan K. Sugimoto K. Okuda T. Katsuya T. Miyata T. Tanabe T. Higaki J. Ogihara T. Yamori Y. Tsujita Y. et al. Kynureninase is a novel candidate gene for hypertension in spontaneously hypertensive rats Hypertens Res. 25 2002 135-140
51. Ragazzi E. Costa C.V. Caparrotta L. Biasiolo M. Bertazzo A. Allegri G. Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits Biochim. Biophys. Acta. 1571 2002 9-17
52. Pawlak D. Tankiewicz A. Matys T. Buczko W. Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure J. Physiol. Pharmacol. 54 2003 175-189
53. Wu H.-Q. Lee S.-C. Scharfman H.E. Schwarcz R. L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat Exp. Neurol. 177 2002 222-232
54. Röver S. Cesura A.M. Huguenin P. Kettler R. Szente A. Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl) benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase J. Med. Chem. 40 1997 4378-4385
55. Fitzgerald D.H. Muirhead K.M. Botting N.P. A comparative study on the inhibition of human and bacterial kynureninase by novel bicyclic kynurenine analogues Bioorg. Med. Chem. 9 2001 983-989
56. Walsh H.A. Leslie P.L. O'Shea K.C. Botting N.P. 2-Amino-4-[3′-hydroxyphenyl]-4-hydroxybutanoic acid; a potent inhibitor of rat and recombinant human kynureninase Bioorg. Med. Chem. Lett. 12 2002 361-363
57. Kocki T. Luchowski P. Luchowska E. Wielosz M. Turski W.A. Urbanska E.M. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II Neurosci. Lett. 346 2003 97 100
58. Luchowski P. Luchowska E. Turski W.A. Urbanska E.M. 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats Neurosci. Lett. 330 2002 49-52
59. Luchowska E. Luchowski P. Wielosz M. Turski W.A. Urbanska E.M. FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices Acta Neurobiol. Exp. (Wars) 63 2003 101-108